Detalles de la búsqueda
1.
A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study).
Clin Infect Dis
; 73(11): e4539-e4548, 2021 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32785589
2.
Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection.
Antimicrob Agents Chemother
; 60(10): 6234-43, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27503659
3.
Imipenem/cilastatin/relebactam efficacy, safety and probability of target attainment in adults with hospital-acquired or ventilator-associated bacterial pneumonia among patients with baseline renal impairment, normal renal function, and augmented renal clearance.
JAC Antimicrob Resist
; 5(2): dlad011, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36880088
4.
Participant- and Disease-Related Factors as Independent Predictors of Treatment Outcomes in the RESTORE-IMI 2 Clinical Trial: A Multivariable Regression Analysis.
Open Forum Infect Dis
; 10(6): ofad225, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37383243
5.
Evaluation of multiday analgesia with etoricoxib in a double-blind, randomized controlled trial using the postoperative third-molar extraction dental pain model.
Clin J Pain
; 29(6): 492-8, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23247002
6.
Evaluation of the dose range of etoricoxib in an acute pain setting using the postoperative dental pain model.
Clin J Pain
; 27(1): 1-8, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21188849
7.
A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infection.
Vaccine
; 24(10): 1501-14, 2006 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-16271808
Resultados
1 -
7
de 7
1
Próxima >
>>